A multinational study of health state preference values associated with chronic myelogenous leukemia.

@article{Szabo2010AMS,
  title={A multinational study of health state preference values associated with chronic myelogenous leukemia.},
  author={Shelagh M Szabo and A. R. Levy and Catherine M. Davis and Tessa L Holyoake and J. C. Gal{\'a}n Cort{\'e}s},
  journal={Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research},
  year={2010},
  volume={13 1},
  pages={103-11}
}
OBJECTIVES Chronic myelogenous leukemia (CML) is a progressive, largely fatal cancer. Emerging treatments may prolong life; however, these result in additional monetary costs. Accurate estimation of their economic impact requires reliable estimates on preferences for health states. The purpose was to estimate preference weights from the general population in four developed countries for standardized health states experienced by persons with CML. METHODS Time trade-off preferences with a 10… CONTINUE READING